Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence

Ovarian cancers are tumors that originate from the different cells of the ovary and account for almost 4% of all the cancers in women globally. More than 30 types of tumors have been identified based on the cellular origins. Epithelial ovarian cancer (EOC) is the most common and lethal type of ovari...

Full description

Bibliographic Details
Main Authors: Roopak Murali, Vaishnavi Balasubramaniam, Satish Srinivas, Sandhya Sundaram, Ganesh Venkatraman, Sudha Warrier, Arun Dharmarajan, Rajesh Kumar Gandhirajan
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/13/4/560
_version_ 1797604350919442432
author Roopak Murali
Vaishnavi Balasubramaniam
Satish Srinivas
Sandhya Sundaram
Ganesh Venkatraman
Sudha Warrier
Arun Dharmarajan
Rajesh Kumar Gandhirajan
author_facet Roopak Murali
Vaishnavi Balasubramaniam
Satish Srinivas
Sandhya Sundaram
Ganesh Venkatraman
Sudha Warrier
Arun Dharmarajan
Rajesh Kumar Gandhirajan
author_sort Roopak Murali
collection DOAJ
description Ovarian cancers are tumors that originate from the different cells of the ovary and account for almost 4% of all the cancers in women globally. More than 30 types of tumors have been identified based on the cellular origins. Epithelial ovarian cancer (EOC) is the most common and lethal type of ovarian cancer which can be further divided into high-grade serous, low-grade serous, endometrioid, clear cell, and mucinous carcinoma. Ovarian carcinogenesis has been long attributed to endometriosis which is a chronic inflammation of the reproductive tract leading to progressive accumulation of mutations. Due to the advent of multi-omics datasets, the consequences of somatic mutations and their role in altered tumor metabolism has been well elucidated. Several oncogenes and tumor suppressor genes have been implicated in the progression of ovarian cancer. In this review, we highlight the genetic alterations undergone by the key oncogenes and tumor suppressor genes responsible for the development of ovarian cancer. We also summarize the role of these oncogenes and tumor suppressor genes and their association with a deregulated network of fatty acid, glycolysis, tricarboxylic acid and amino acid metabolism in ovarian cancers. Identification of genomic and metabolic circuits will be useful in clinical stratification of patients with complex etiologies and in identifying drug targets for personalized therapies against cancer.
first_indexed 2024-03-11T04:46:14Z
format Article
id doaj.art-fc4af6e332fd4b70ae83324d7f3f785a
institution Directory Open Access Journal
issn 2218-1989
language English
last_indexed 2024-03-11T04:46:14Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj.art-fc4af6e332fd4b70ae83324d7f3f785a2023-11-17T20:25:13ZengMDPI AGMetabolites2218-19892023-04-0113456010.3390/metabo13040560Deregulated Metabolic Pathways in Ovarian Cancer: Cause and ConsequenceRoopak Murali0Vaishnavi Balasubramaniam1Satish Srinivas2Sandhya Sundaram3Ganesh Venkatraman4Sudha Warrier5Arun Dharmarajan6Rajesh Kumar Gandhirajan7Department of Human Genetics, Faculty of Biomedical Sciences Technology and Research, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Porur, Chennai 600116, IndiaDepartment of Human Genetics, Faculty of Biomedical Sciences Technology and Research, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Porur, Chennai 600116, IndiaDepartment of Radiation Oncology, Sri Ramachandra Medical College & Research Institute, Sri Ramachandra Institute of Higher Education & Research (Deemed to be University), Porur, Chennai 600116, IndiaDepartment of Pathology, Sri Ramachandra Medical College & Research Institute, Sri Ramachandra Institute of Higher Education & Research (Deemed to be University), Porur, Chennai 600116, IndiaDepartment of Human Genetics, Faculty of Biomedical Sciences Technology and Research, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Porur, Chennai 600116, IndiaDivision of Cancer Stem Cells and Cardiovascular Regeneration, School of Regenerative Medicine, Manipal Academy of Higher Education (MAHE), Bangalore 560065, IndiaDepartment of Biomedical Sciences, Faculty of Biomedical Sciences Technology and Research, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Porur, Chennai 600116, IndiaDepartment of Human Genetics, Faculty of Biomedical Sciences Technology and Research, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Porur, Chennai 600116, IndiaOvarian cancers are tumors that originate from the different cells of the ovary and account for almost 4% of all the cancers in women globally. More than 30 types of tumors have been identified based on the cellular origins. Epithelial ovarian cancer (EOC) is the most common and lethal type of ovarian cancer which can be further divided into high-grade serous, low-grade serous, endometrioid, clear cell, and mucinous carcinoma. Ovarian carcinogenesis has been long attributed to endometriosis which is a chronic inflammation of the reproductive tract leading to progressive accumulation of mutations. Due to the advent of multi-omics datasets, the consequences of somatic mutations and their role in altered tumor metabolism has been well elucidated. Several oncogenes and tumor suppressor genes have been implicated in the progression of ovarian cancer. In this review, we highlight the genetic alterations undergone by the key oncogenes and tumor suppressor genes responsible for the development of ovarian cancer. We also summarize the role of these oncogenes and tumor suppressor genes and their association with a deregulated network of fatty acid, glycolysis, tricarboxylic acid and amino acid metabolism in ovarian cancers. Identification of genomic and metabolic circuits will be useful in clinical stratification of patients with complex etiologies and in identifying drug targets for personalized therapies against cancer.https://www.mdpi.com/2218-1989/13/4/560ovarian cancertumor metabolismoncogenestumor suppressor genes
spellingShingle Roopak Murali
Vaishnavi Balasubramaniam
Satish Srinivas
Sandhya Sundaram
Ganesh Venkatraman
Sudha Warrier
Arun Dharmarajan
Rajesh Kumar Gandhirajan
Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence
Metabolites
ovarian cancer
tumor metabolism
oncogenes
tumor suppressor genes
title Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence
title_full Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence
title_fullStr Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence
title_full_unstemmed Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence
title_short Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence
title_sort deregulated metabolic pathways in ovarian cancer cause and consequence
topic ovarian cancer
tumor metabolism
oncogenes
tumor suppressor genes
url https://www.mdpi.com/2218-1989/13/4/560
work_keys_str_mv AT roopakmurali deregulatedmetabolicpathwaysinovariancancercauseandconsequence
AT vaishnavibalasubramaniam deregulatedmetabolicpathwaysinovariancancercauseandconsequence
AT satishsrinivas deregulatedmetabolicpathwaysinovariancancercauseandconsequence
AT sandhyasundaram deregulatedmetabolicpathwaysinovariancancercauseandconsequence
AT ganeshvenkatraman deregulatedmetabolicpathwaysinovariancancercauseandconsequence
AT sudhawarrier deregulatedmetabolicpathwaysinovariancancercauseandconsequence
AT arundharmarajan deregulatedmetabolicpathwaysinovariancancercauseandconsequence
AT rajeshkumargandhirajan deregulatedmetabolicpathwaysinovariancancercauseandconsequence